Active Monitoring vs. Treatment: Navigating Prostate Health Decisions - Urology

More Info

---

Navigating prostate health decisions, especially after a prostatectomy, can be quite challenging. Your situation involves several key factors that need to be considered when deciding between active monitoring and further treatment options.
First, let's break down your medical history and current status. You underwent a prostatectomy due to significant urinary difficulties, with a pre-operative PSA level of 18.9, which is notably elevated. Post-surgery, your PSA dropped to 0.93, indicating that the surgery was effective in removing the cancerous tissue. The Gleason score of 6 suggests a moderately differentiated cancer, which is generally considered less aggressive compared to higher scores. Additionally, the fact that only 0.03% of the resected tissue contained cancer cells is a positive sign, as is the absence of metastasis on both bone and ultrasound scans.
Given these factors, your physician's recommendation of either active treatment or active surveillance is not uncommon. Active surveillance is often recommended for patients with low-risk prostate cancer, particularly when the cancer appears to be contained and not aggressive. This approach involves regular monitoring of PSA levels, digital rectal exams, and possibly repeat biopsies to ensure that the cancer does not progress.
The decision to pursue active monitoring can be beneficial for several reasons. First, it allows you to avoid the potential side effects and complications associated with aggressive treatments such as radiation or hormone therapy, which can include fatigue, sexual dysfunction, and other health issues. Since you also have a history of hypertension, managing your overall health without the added burden of aggressive cancer treatment could be advantageous.

However, it is crucial to understand that active monitoring does not mean neglecting the cancer. It requires a commitment to regular follow-ups and being vigilant for any changes in your PSA levels or symptoms. If there is a significant rise in PSA or any new symptoms arise, you would then transition to active treatment. This approach is particularly suitable for patients who are older or have other health conditions that may complicate more aggressive treatments.

On the other hand, if you have concerns about the potential for cancer progression or if your PSA levels begin to rise significantly, discussing more aggressive treatment options with your healthcare provider would be prudent. Treatments such as radiation therapy or hormone therapy can be effective but come with their own sets of risks and side effects.

In conclusion, given your current low PSA level, the favorable pathology report, and the absence of metastasis, starting with active monitoring seems to be a reasonable approach. However, it is essential to maintain open communication with your healthcare provider, regularly assess your health status, and be prepared to make adjustments to your treatment plan as necessary. Always consider your personal comfort level with monitoring versus treatment, and ensure that your decisions align with your overall health goals and quality of life.